bluuebunny/crossref_metadata_2025_split huggingface dataset:
A Systematic Review on 3D-Printed Imaging and Dosimetry Phantoms in Radiation Therapy
Authors: Tino Rance , Yeo Adam , Leary Martin , Brandt Milan , Kron Tomas 
Published: September 2019

Introduction: Additive manufacturing or 3-dimensional printing has become a widespread technology with many applications in medicine. We have conducted a systematic review of its application in radiation oncology with a particular emphasis on the creation of phantoms for image quality assessment and radiation dosimetry. Traditionally used phantoms for quality assurance in radiotherapy are often constraint by simplified geometry and homogenous nature to perform imaging analysis or pretreatment dosimetric verification. Such phantoms are limited due to their ability in only representing the average human body, not only in proportion and radiation properties but also do not accommodate pathological features. These limiting factors restrict the patient-specific quality assurance process to verify image-guided positioning accuracy and/or dose accuracy in “water-like” condition. Methods and Results: English speaking manuscripts published since 2008 were searched in 5 databases (Google Scholar, Scopus, PubMed, IEEE Xplore, and Web of Science). A significant increase in publications over the 10 years was observed with imaging and dosimetry phantoms about the same total number (52 vs 50). Key features of additive manufacturing are the customization with creation of realistic pathology as well as the ability to vary density and as such contrast. Commonly used printing materials, such as polylactic acid, acrylonitrile butadiene styrene, high-impact polystyrene and many more, are utilized to achieve a wide range of achievable X-ray attenuation values from −1000 HU to 500 HU and higher. Not surprisingly, multimaterial printing using the polymer jetting technology is emerging as an important printing process with its ability to create heterogeneous phantoms for dosimetry in radiotherapy. Conclusion: Given the flexibility and increasing availability and low cost of additive manufacturing, it can be expected that its applications for radiation medicine will continue to increase.
Prognostic impact of percutaneous coronary intervention in octogenarians with non-ST elevation myocardial infarction: A report from SWEDEHEART
Authors: Völz Sebastian , Petursson Petur , Angerås Oskar , Odenstedt Jacob , Ioanes Dan , Haraldsson Inger , Dworeck Christian , Hirlekar Geir , Redfors Björn , Myredal Anna , Libungan Berglind , Albertsson Per , Råmunddal Truls , Omerovic Elmir 
Published: September 2019

Aims:
Percutaneous coronary intervention (PCI) improves outcomes in non-ST elevation acute coronary syndromes (NSTE-ACSs). Octogenarians, however, were underrepresented in the pivotal trials. This study aimed to assess the effect of PCI in patients ≥80 years old.

Methods and results:
We used data from the SWEDEHEART registry for all hospital admissions at eight cardiac care centres within Västra Götaland County. Consecutive patients ≥80 years old admitted for NSTE-ACS between January 2000 and December 2011 were included. We performed instrumental variable analysis with propensity score. The primary endpoint was all-cause mortality at 30 days and one year after index hospitalization. During the study period 5200 patients fulfilled the inclusion criteria. In total, 586 (11.2%) patients underwent PCI, the remaining 4613 patients were treated conservatively. Total mortality at 30 days was 19.4% (1007 events) and 39.4% (1876 events) at one year. Thirty-day mortality was 20.7% in conservatively treated patients and 8.5% in the PCI group (adjusted odds ratio 0.34; 95% confidence interval 0.12–0.97, p = 0.044). One-year mortality was 42.1% in the conservatively treated group and 16.3% in the PCI group (adjusted odds ratio 0.97; 95% confidence interval 0.36–2.51, p = 0.847).

Conclusions:
PCI in octogenarians with NSTE-ACS was associated with a lower risk of mortality at 30 days. However, this survival benefit was not sustained during the entire study-period of one-year.
Low Socioeconomic Status Is Associated With Increased Complication Rates: Are Risk Adjustment Models Necessary in Cervical Spine Surgery?
Authors: Lieber Alexander M. , Boniello Anthony J. , Kerbel Yehuda E. , Petrucelli Philip , Kavuri Venkat , Jakoi Andre , Khalsa Amrit S. 
Published: September 2019

Study Design: Retrospective cohort study. Objectives: The objective of this study was to determine whether lower socioeconomic status was associated with increased resource utilization following anterior discectomy and fusion (ACDF). Methods: The National Inpatient Sample database was queried for patients who underwent a primary, 1- to 2-level ACDF between 2005 and 2014. Trauma, malignancy, infection, and revision surgery were excluded. The top and bottom income quartiles were compared. Demographics, medical comorbidities, length of stay, complications, and hospital cost were compared between patients of top and bottom income quartiles. Results: A total of 69 844 cases were included. The bottom income quartile had a similar mean hospital stay (2.04 vs 1.77 days, P = .412), more complications (2.45% vs 1.77%, P < .001), and a higher mortality rate (0.18% vs 0.11%, P = .016). Multivariate analysis revealed bottom income quartile was an independent risk factor for complications (odds ratio = 1.135, confidence interval = 1.02-1.26). Interestingly, the bottom income quartile experienced lower mean hospital costs ($17 041 vs $17 958, P < .001). Conclusion: Patients in the lowest income group experienced more complications even after adjusting for comorbidities. Therefore, risk adjustment models, including socioeconomic status, may be necessary to avoid potential problems with access to orthopedic spine care for this patient population.
Institutional Experience of Treatment and Outcomes for Cutaneous Periauricular Squamous Cell Carcinoma
Authors: Kovatch Kevin J. , Smith Joshua D. , Birkeland Andrew C. , Hanks John E. , Jawad Rasha , McLean Scott A. , Durham Alison B. , Srinivasan Ashok , McHugh Jonathan B. , Basura Gregory J. 
Published: September 2019

ObjectivesTo report our institutional experience, management, and outcomes of cutaneous periauricular squamous cell carcinoma (SCC).Study DesignRetrospective chart review.SettingTertiary academic center.SubjectsPatients undergoing treatment of cutaneous periauricular SCC from 2000 to 2016.ResultsA total of 112 patients had a median follow‐up of 24.5 months, a mean ± SD age of 75.7 ± 10.6 years, and a strong male predominance (93.8%). Site distribution shows 87 (77.7%) auricular, 26 (23.2%) preauricular, and 10 (8.8%) postauricular lesions. Of auricular lesions, tumors involved the tragus (n = 3, 3.4%), helix/antihelix (n = 47, 54.0%), conchal bowl (n = 31, 35.6%), external auditory canal (n = 18, 16.1%), and lobule (n = 3, 3.4%). Most patients presented at stage I (52.7%) versus stages II (28.6%), III (6.3%), and IV (12.5%). Patients were largely treated surgically with primary tumor resection ranging from wide local excision to lateral temporal bone resection (± parotidectomy and neck dissection), with 17.0% and 5.4% receiving adjuvant radiation and chemoradiation, respectively. Metastatic spread was seen to the parotid (25.9%) and neck (26.8%), with most common cervical spread to level II. Overall survival, disease‐specific survival, and disease‐free survival at 3 years were 62%, 89%, and 56%, respectively. Nodal disease was associated with worse disease‐specific survival (P <. 001) and disease‐free survival (P =. 042). Pre‐ and postauricular sites were associated with worse overall survival (P =. 007) relative to auricular sites.ConclusionAmong cutaneous SCC, periauricular subsites pose treatment challenges related to surrounding anatomy and represent a unique tumor population. The reported propensity toward recurrence and patterns of metastasis may better guide treatment of aggressive tumors to include regional nodal dissection.
Local immune and microbiological responses to mucosal administration of a Liposome-TLR agonist immunotherapeutic in dogs
Authors: Wheat William , Chow Lyndah , Kuzmik Alana , Soontararak Sirikul , Kurihara Jade , Lappin Michael , Dow Steven 
Published: September 2019

Abstract

Background
Non-specific immunotherapeutics have been evaluated previously in dogs, primarily for cancer treatment. However, there remains a need for a more broadly targeted, general purpose immunotherapeutic capable of activating innate immune defenses for non-specific protection or early treatment of viral and bacterial infections. To address need, our group has developed a liposomal immune stimulant (liposome-TLR complexes, LTC) containing TLR 3 and 9 agonists specifically designed to activate mucosal immune defenses in sites such as nasal cavity and oropharynx, following topical delivery. In this study, we evaluated the local immune stimulatory properties of LTC in vitro and in healthy purpose-bred dogs, including activation of cellular recruitment and cytokine production. The ability of LTC treatment to elicit effective antiviral immunity was assessed in dogs following a canine herpesvirus outbreak, and the impact of LTC treatment on the local microbiome of the oropharynx was also investigated.

Results
These studies revealed that LTC potently activated innate immune responses in vitro and triggered significant recruitment of inflammatory monocytes and T cells into the nasal cavity and oropharynx of healthy dogs. Administration of LTC to dogs shortly after an outbreak of canine herpesvirus infection resulted in significant reduction in clinical signs of infection. Interestingly, administration of LTC to healthy dogs did not disrupt the microbiome in the oropharynx, suggesting resiliency of the microflora to transient immune activation.

Conclusions
Taken together, these results indicate that LTC administration mucosally to dogs can trigger local innate immune activation and activation of antiviral immunity, without significantly disrupting the composition of the local microbiome. Thus, the LTC immune stimulant has potential for use as a non-specific immunotherapy for prevention or early treatment of viral and bacterial infections in dogs.
Water treadmill exercise reduces equine limb segmental accelerations and increases shock attenuation
Authors: Greco-Otto Persephone , Baggaley Michael , Edwards W. B. , Léguillette Renaud 
Published: September 2019

AbstractBackgroundEquine water treadmills (WTs) are growing in popularity because they are believed to allow for high resistance, low impact exercise. However, little is known about the effect of water height on limb loading. The aim of this study was to evaluate the effect of water height and speed on segmental acceleration and impact attenuation during WT exercise in horses. Three uniaxial accelerometers (sampling rate: 2500 Hz) were secured on the left forelimb (hoof, mid-cannon, mid-radius). Horses walked at two speeds (S1: 0.83 m/s, S2: 1.39 m/s) and three water heights (mid-cannon, carpus, stifle), with a dry WT control. Peak acceleration of each segment was averaged over five strides, attenuation was calculated, and stride frequency was estimated by the time between successive hoof contacts. Linear mixed effects models were used to examine the effects of water height, speed, and accelerometer location on peak acceleration, attenuation and stride frequency (p < 0.05).ResultsPeak acceleration at all locations was lower with water of any height compared to the dry control (p < 0.0001). Acceleration was reduced with water at the height of the stifle compared to mid-cannon water height (p = 0.02). Water at the height of the stifle attenuated more impact than water at the height of the cannon (p = 0.0001).ConclusionsWater immersion during treadmill exercise reduced segmental accelerations and increased attenuation in horses. WT exercise may be beneficial in the rehabilitation of lower limb injuries in horses.
Terahertz spectral imaging based quantitative determination of spatial distribution of plant leaf constituents
Authors: Zang Ziyi , Wang Jie , Cui Hong-Liang , Yan Shihan 
Published: September 2019

Abstract

Background
Plant leaves have heterogeneous structures composed of spatially variable distribution of liquid, solid, and gaseous matter. Such contents and distribution characteristics correlate with the leaf vigor and phylogenic traits. Recently, terahertz (THz) techniques have been proved to access leaf water content and spatial heterogeneity distribution information, but the solid matter content and gas network information were usually ignored, even though they also affect the THz dielectric function of the leaf.

Results
A particle swarm optimization algorithm is employed for a one-off quantitative assay of spatial variability distribution of the leaf compositions from THz data, based on an extended Landau–Lifshitz–Looyenga model, and experimentally verified using Bougainvillea spectabilis leaves. A good agreement is demonstrated for water and solid matter contents between the THz-based method and the gravimetric analysis. In particular, the THz-based method shows good sensitivity to fine-grained differences of leaf growth and development stages. Furthermore, such subtle features as damages and wounds in leaf could be discovered through THz detection and comparison regarding spatial heterogeneity of component contents.

Conclusions
This THz imaging method provides quantitative assay of the leaf constituent contents with the spatial distribution feature, which has the potential for applications in crop disease diagnosis and farmland cultivation management.
Analysis of percutaneous kyphoplasty or short-segmental fixation combined with vertebroplasty in the treatment of Kummell disease
Authors: Lu Wei , Wang Long , Xie Chunlin , Teng Zhaowei , Han Gonghai , Shi Rongmao , Liang Jinlong , Lu Sheng 
Published: September 2019

AbstractBackgroundIn recent years, short segment internal fixation combined with vertebroplasty (SSF + VP) has provided a new option for the treatment of Kummell disease (KD). The purpose of this study is to evaluate the efficacy of percutaneous kyphoplasty (PKP) and SSF + VP, to provide evidence-based medical support for the decision-making process when treating KD patients without neurological deficits.MethodsDatabases including MEDLINE (PubMed) and EMBASE (Ovid) (1947 to April 6, 2019) were searched for PKP and short-segmental fixation combined with vertebroplasty (SSF + VP) to treat Kummell disease in randomized controlled trials (RCTs) or cohort studies. Two investigators independently evaluated the eligibility of the studies retrieved from the databases based on the predetermined selection criteria. The postoperative evaluation indexes included operation time, bleeding volume, visual analog scale (VAS) score, Oswestry Disability Index (ODI) score, local vertebral Cobb angle, and cement leakage. When the data were significant, a random-effects model was used for analysis. In contrast, when the results showed no statistical heterogeneity, a fixed-effects model was used to estimate the overall effect sizes.ResultsThree retrospective case-control studies were included in the final analysis. The differences in the bleeding volume and operation time were statistically significant, and the combined weighted mean differences (WMDs) (95% CI) were − 0.204.46 (− 210.97, − 197.93) and − 98.98 (− 141.63, 56.32), respectively.The combined data showed that the differences in VAS score, ODI score, local vertebral Cobb angle, and cement leakage were not statistically significant.ConclusionsThis analysis demonstrates that the PKP and SSF + VP methods are safe and effective in treating Kummell disease patients without neurological symptoms. However, PKP can shorten the operation time and reduce the volume of blood loss.
SCP2-mediated cholesterol membrane trafficking promotes the growth of pituitary adenomas via Hedgehog signaling activation
Authors: Ding Xiao , Fan Kexia , Hu Jintao , Zang Zhenle , Zhang Shunli , Zhang Yin , Lin Zhichao , Pei Xiangdong , Zheng Xin , Zhu Feng , Yang Hui , Li Song 
Published: September 2019

AbstractBackgroundMetabolic reprogramming is an important characteristic of tumors. In the progression of pituitary adenomas (PA), abnormal glucose metabolism has been confirmed by us before. However, whether cholesterol metabolism is involved in the process of PA remains unclear. This study aimed to investigate whether abnormal cholesterol metabolism could affect the progression of PA.MethodsWe analyzed the expression of sterol carrier protein 2 (SCP2) in 40 surgical PA samples. In vitro experiments and xenograft models were used to assess the effects of SCP2 and cholesterol on proliferation of PA. The incidence of hypercholesterolemia between 140 PA patients and 100 heathy controls were compared.ResultsWe found an upregulation of SCP2 in PA samples, especially in tumors with high proliferation index. Forced expression of SCP2 promoted PA cell lines proliferation in vitro. Furthermore, SCP2 regulated cholesterol trafficking from cytoplasm to membrane in GH3 cells, and extracellularly treating GH3 cells and primary PA cells with methyl-β-cyclodextrin/cholesterol complex to mimic membrane cholesterol concentration enhanced cell proliferation, which suggested a proliferative effect of cholesterol. Mechanistically, cholesterol induced activation of PKA/SUFU/GLI1 signaling via smoothened receptor, which was well-known as Hedgehog signaling, resulting in inhibiting apoptosis and promoting cell cycle. Accordingly, activation of Hedgehog signaling was also confirmed in primary PA cells and surgical PA samples. In vivo, SCP2 overexpression and high cholesterol diet could promote tumor growth. Intriguingly, the incidence of hypercholesterolemia was significantly higher in PA patients than healthy controls.ConclusionsOur data indicated that dysregulated cholesterol metabolism could promote PA growth by activating Hedgehog signaling, supporting a potential tumorigenic role of cholesterol metabolism in PA progression.
Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells
Authors: Chen Yibing , Mi Yanjun , Zhang Xiaofei , Ma Qian , Song Yucen , Zhang Liwei , Wang Dandan , Xing Jinliang , Hou Benxin , Li Haolong , Jin Huan , Du Wei , Zou Zhengzhi 
Published: September 2019

Abstract

Background
Dihydroartemisinin (DHA) has been shown to exert anticancer activity through iron-dependent reactive oxygen species (ROS) generation, which is similar to ferroptosis, a novel form of cell death. However, whether DHA causes ferroptosis in glioma cells and the potential regulatory mechanisms remain unclear.

Methods
Effects of DHA on the proliferation, cell death, ROS and lipid ROS generation as well as reduced gluthione consumption were assessed in glioma cells with or without ferroptosis inhibitor. The biological mechanisms by which glioma cells attenuate the pro-ferroptotic effects of DHA were assessed using molecular methods.

Results
DHA induced ferroptosis in glioma cells, as characterized by iron-dependent cell death accompanied with ROS generation and lipid peroxidation. However, DHA treatment simultaneously activated a feedback pathway of ferroptosis by increasing the expression of heat shock protein family A (Hsp70) member 5 (HSPA5). Mechanistically, DHA caused endoplasmic reticulum (ER) stress in glioma cells, which resulted in the induction of HSPA5 expression by protein kinase R-like ER kinase (PERK)-upregulated activating transcription factor 4 (ATF4). Subsequent HSPA5 upregulation increased the expression and activity of glutathione peroxidase 4 (GPX4), which neutralized DHA-induced lipid peroxidation and thus protected glioma cells from ferroptosis. Inhibition of the PERK-ATF4-HSPA5-GPX4 pathway using siRNA or small molecules increased DHA sensitivity of glioma cells by increasing ferroptosis both in vitro and in vivo.

Conclusions
Collectively, these data suggested that ferroptosis might be a novel anticancer mechanism of DHA in glioma and HSPA5 may serve as a negative regulator of DHA-induced ferroptosis. Therefore, inhibiting the negative feedback pathway would be a promising therapeutic strategy to strengthen the anti-glioma activity of DHA.
Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study
Authors: Gao Yan , Li Yuan , Zhang Chunyu , Han Jinsong , Liang Huamao , Zhang Kun , Guo Hongyan 
Published: September 2019

AbstractObjectiveTo compare the chemoresistance and survival in patients with stage IIIC or IV epithelial ovarian cancer who were treated with neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) or primary debulking surgery (PDS). The clinical characteristics of patients who benefited from NACT were further evaluated.MethodsWe retrospectively analyzed 220 patients who underwent NACT followed by IDS or PDS from January 2002 to December 2016. Differences in clinicopathological features, chemoresistance and prognosis were analyzed.ResultsThe incidence rate for optimal cytoreduction and chemoresistance in the NACT group was relatively higher than PDS group. No differences were observed in progression free survival or overall survival. Patients without macroscopic RD in NACT group (NACT-R0) had a similar prognosis compared to those in PDS group who had RD<1 cm, and a relatively better prognosis compared to the PDS group that had RD ≥ 1 cm. The survival curve showed that patients in NACT-R0 group that were chemosensitive seemed to have a better prognosis compared to patients in PDS group that had RD.ConclusionPatients without RD after PDS had the best prognosis, whereas patients with RD after NACT followed by IDS had the worst. However, even if patients achieved no RD, their prognosis varied depending on chemosensitivity. Survival was better in patients who were chemosensitive compared to thosewho underwent PDS but had RD. Hence evaluating the chemosensitivity and feasibility of complete cytoreduction in advance is crucial.